DUBLIN–(BUSINESS WIRE)–The “Atopic Dermatitis Drugs – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s providing.
Global Atopic Dermatitis Drugs Market to Reach $7.4 Billion by 2027
Amid the COVID-19 disaster, the worldwide marketplace for Atopic Dermatitis Drugs estimated at US$5.1 Billion within the 12 months 2020, is projected to achieve a revised dimension of US$7.4 Billion by 2027, rising at a CAGR of 5.4% over the evaluation interval 2020-2027.
Corticosteroids, one of many segments analyzed within the report, is projected to document a 5.7% CAGR and attain US$3.2 Billion by the tip of the evaluation interval. After an early evaluation of the enterprise implications of the pandemic and its induced financial disaster, progress within the Calcineurin Inhibitors section is readjusted to a revised 5.1% CAGR for the following 7-year interval.
The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 8.2% CAGR
The Atopic Dermatitis Drugs market within the U.S. is estimated at US$1.4 Billion within the 12 months 2020. China, the world’s second largest financial system, is forecast to achieve a projected market dimension of US$1.6 Billion by the 12 months 2027 trailing a CAGR of 8.3% over the evaluation interval 2020 to 2027. Among the opposite noteworthy geographic markets are Japan and Canada, every forecast to develop at 2.9% and 4.8% respectively over the 2020-2027 interval. Within Europe, Germany is forecast to develop at roughly 3.3% CAGR.
Biologics Segment to Record 6.8% CAGR
In the worldwide Biologics section, USA, Canada, Japan, China and Europe will drive the 6.3% CAGR estimated for this section. These regional markets accounting for a mixed market dimension of US$312.4 Million within the 12 months 2020 will attain a projected dimension of US$478.6 Million by the shut of the evaluation interval.
China will stay among the many quickest rising on this cluster of regional markets. Led by nations equivalent to Australia, India, and South Korea, the market in Asia-Pacific is forecast to achieve US$997.2 Million by the 12 months 2027, whereas Latin America will increase at a 8.1% CAGR by means of the evaluation interval.
Select Competitors (Total 43 Featured):
- Allergan Plc
- Anacor Pharmaceutical Inc.
- Astellas Pharma, Inc.
- Bayer AG
- Bristol-Myers Squibb Company
- Encore Dermatology
- Leo Pharma
- Meda Pharmaceuticals
- Novartis International AG
- Regeneron Pharmaceuticals, Inc.
- Valent Pharmaceutical Inc.
Key Topics Covered:
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS
- Total Companies Profiled: 43
For extra details about this report go to https://www.researchandmarkets.com/r/ctzrta